Binding of protein S to domain-specific monoclonal antibodies and enhancement of APC-mediated cleavage of FVa at Arg306 by protein S
. | WT PS . | Chimera I . | Chimera II . | Chimera III . |
---|---|---|---|---|
MK 21 (Gla) | 1.93 ± 0.78 | 1.67 ± 0.33 | 1.62 ± 0.78 | 1.92 ± 0.83 |
MK 41 (EGF3-EGF4) | 0.76 ± 0.18 | 1.00 ± 0.32 | 0.50 ± 0.26 | 0.75 ± 0.46 |
MK 54 (EGF1) | 0.25 ± 0.13 | 0.21 ± 0.12 | 0.17 ± 0.06 | 0.20 ± 0.07 |
MK 67 (TSR) | 0.22 ± 0.09 | 0.18 ± 0.03 | 0.13 ± 0.06 | 0.15 ± 0.09 |
EC50 for FVaR506Q/R679Q inactivation | 5.18 ± 0.36 | 5.20 ± 1.19 | 6.31 ± 0.53 | 4.92 ± 0.95 |
. | WT PS . | Chimera I . | Chimera II . | Chimera III . |
---|---|---|---|---|
MK 21 (Gla) | 1.93 ± 0.78 | 1.67 ± 0.33 | 1.62 ± 0.78 | 1.92 ± 0.83 |
MK 41 (EGF3-EGF4) | 0.76 ± 0.18 | 1.00 ± 0.32 | 0.50 ± 0.26 | 0.75 ± 0.46 |
MK 54 (EGF1) | 0.25 ± 0.13 | 0.21 ± 0.12 | 0.17 ± 0.06 | 0.20 ± 0.07 |
MK 67 (TSR) | 0.22 ± 0.09 | 0.18 ± 0.03 | 0.13 ± 0.06 | 0.15 ± 0.09 |
EC50 for FVaR506Q/R679Q inactivation | 5.18 ± 0.36 | 5.20 ± 1.19 | 6.31 ± 0.53 | 4.92 ± 0.95 |
PS, protein S.
Kd app/EC50 values obtained from 3 independent experiments are given in nanomolars and are expressed as mean ± SD.